XNAS
NXL
Market cap9mUSD
Jul 09, Last price
0.45USD
1D
8.89%
1Q
12.49%
IPO
-73.25%
Name
Nexalin Technology Inc
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Based in Houston, Texas, Nexalin Technology, Inc., founded in 2021, is a medical device firm dedicated to creating and advancing neurostimulation solutions. These products are designed to address mental health conditions within the United States and China. The company's primary offering, the Nexalin Device, is a licensed, non-invasive, and drug-free therapeutic option for managing anxiety and insomnia. This device functions by emitting a unique, patented frequency waveform that elicits a beneficial response from mid-brain structures implicated in various mental health disorders. Furthermore, Nexalin is currently developing its "Generation 2" medical device, which is undergoing clinical trials for potential treatment of opiate-related substance abuse, chronic pain, Alzheimer's disease, and dementia.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||